Novak Djokovic has 80 per cent stake in biotech firm developing Covid drug

over 2 years in Standard

Novak Djokovic has been revealed as a majority shareholder in a Danish biotech firm working looking to treat Covid without getting vaccinated.

Mentioned in this news
Share it on